Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Monofer vs Oral Iron in IBD with Iron Deficiency Anaemia
NCT01017614Phase 3Completed
- Sponsor
- Pharmacosmos
- Start
- Oct 2009
- Primary completion
- Jul 2012
- Modality
- Inorganic Nanoparticles, Small Molecules
- Countries
- 3
01
Overview
A Phase 3 trial of ferric derisomaltose in iron deficiency anemia (IDA), sponsored by Pharmacosmos. Started Oct 2009; status: completed.
02
Drugs
ferric derisomaltose
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on NCT01017614.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01017614.